Depression is the most prevalent psychiatric disorder in the world, affecting 4.4% of the
global population. Despite an array of treatment modalities, depressive disorders remain …

Purpose of review This manuscript reviews the epidemiological data linking psychosocial
stress to cardiovascular disease (CVD), describes recent advances in understanding the …

Cardiovascular diseases and depression are significant health burdens and increasing
evidence suggests a causal relationship between them. The incidence of depression among …

Background: Depression is a common complication of cardiovascular disease, which
deteriorates cardiac function. Shuangxinfang (psycho-cardiology formula, PCF) was …

Serotonin, also known as 5-hydroxytryptamine (5-HT) is a well-known neurotransmitter in
the central nervous system (CNS), but also plays a significant role in peripheral tissues …

Positron emission tomography (PET) imaging can yield unique mechanistic insights into the
pathophysiology of atherosclerosis. 18 F-fluorodeoxyglucose (18 F-FDG), a radiolabeled …

Cardiovascular disease (CVD) is the leading cause of death in the United States and
worldwide. Psychosocial stress is an important risk factor implicated in a higher incidence of …

Background Major depressive disorders represent a significant burden to society, and it is
recommended that antidepressant therapy should last at least 6 months. In Italy …

COVID-19 has caused a global pandemic of anxiety, fear and uncertainty. National
lockdowns, high mortality, social isolation, economic recession, job losses and food …

Purpose This study compares the risks of arrhythmia among patients with depression
receiving selective serotonin reuptake inhibitors (SSRIs) and those receiving other classes …